Neurorehabilitation News

Poor performance on cognitive tests assessing memory-related motor function and verbal recall is linked to probable PTSD in adults with traumatic brain injury, according to a cross-sectional study published in Brain and Spine.

The FDA has granted investigational device exemption to clinical-stage medical device company CereVasc for a pilot trial of its eShunt System in patients with normal pressure hydrocephalus.

Increases in generalized and visceral adipose tissue were linked to reduction of cognitive function in adults, when adjusted for other health factors, per a Canadian cross-sectional cohort study published in JAMA Network Open.

The FDA granted orphan drug exclusivity for JZP258, an oral low-sodium oxybate solution for the treatment of idiopathic hypersomnia in adults, according to Jazz Pharmaceuticals.

The American Academy of Neurology has updated a guideline for treating painful diabetic neuropathy using oral and topical treatments.

Neuroscience firm Inscopix, Inc. introduced a cloud-based data management system intended to ease collection, organization and sharing of neuroscience research.

Rapid intensive care, including endovascular therapy after stroke, proved to be a factor in less memory loss, according to results of a survey published in the American Academy of Neurology.

Patients with COVID-19-associated disorders of consciousness who survived the infection were highly likely to regain consciousness, according to results of a prospective, multimodal study.

A smartphone application may help clinicians detect concussion biomarkers, according to study results published in Life.

In 2019, more than 67 million adults in the U.S. reported having a disability, a 1% increase since the prevalence was last examined in 2016, according to findings published in JAMA Network Open.